Atherosclerosis Plus
Title Abbreviation
Atheroscler Plus
Electronic ISSN
2667-0895
Readership
Cardiologists, Clinical Pharmacologists, Clinicians, Diabetologists, General Practitioners, HyperTension Specialists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Pathologists, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine, Vascular Medicine Specialists
Scope
Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions. Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. Finally, the journal periodically publishes special theme issues devoted to areas of current interest.
Sponsoring Association(s)
European Atherosclerosis Society (EAS)
Publisher Name
Elsevier B.V.
Impact Factor
JCR Categories/Rank
Submission to Acceptance
Acceptance to Online Publication
Frequency
Author Submission Guidelines